 | • レポートコード：GIR-107A12526 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍用小分子薬剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍用小分子薬剤の種類別市場規模（化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍用小分子薬剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis、Pfizer、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、AbbVie、Sanofi、Takeda、Eli Lilly、Bayer、AstraZeneca、Astellas、Merck、Biogen Idec、Eisai、Teva、Otsuka、Ipsen、Gilead Sciences、Exelixis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他 ・用途別分析2016年-2026年：血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他 ・腫瘍用小分子薬剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍用小分子薬剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍用小分子薬剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍用小分子薬剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍用小分子薬剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology Small Molecule Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology Small Molecule Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oncology Small Molecule Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oncology Small Molecule Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other
Market segment by Application, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other
Market segment by players, this report covers
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Oncology Small Molecule Drugs
1.2 Classification of Oncology Small Molecule Drugs by Type
1.2.1 Overview: Global Oncology Small Molecule Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oncology Small Molecule Drugs Revenue Market Share by Type in 2020
1.2.3 Chemotherapy Drugs
1.2.4 Immunomodulating Drugs
1.2.5 Targeted Therapy Drugs
1.2.6 Hormonal Therapy
1.2.7 Other
1.3 Global Oncology Small Molecule Drugs Market by Application
1.3.1 Overview: Global Oncology Small Molecule Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Global Oncology Small Molecule Drugs Market Size & Forecast
1.5 Global Oncology Small Molecule Drugs Market Size and Forecast by Region
1.5.1 Global Oncology Small Molecule Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oncology Small Molecule Drugs Market Size by Region, (2016-2021)
1.5.3 North America Oncology Small Molecule Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Oncology Small Molecule Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oncology Small Molecule Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Oncology Small Molecule Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oncology Small Molecule Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Small Molecule Drugs Market Drivers
1.6.2 Oncology Small Molecule Drugs Market Restraints
1.6.3 Oncology Small Molecule Drugs Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology Small Molecule Drugs Product and Solutions
2.1.4 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Oncology Small Molecule Drugs Product and Solutions
2.2.4 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Oncology Small Molecule Drugs Product and Solutions
2.3.4 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business
2.4.3 Celgene Oncology Small Molecule Drugs Product and Solutions
2.4.4 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Celgene Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Product and Solutions
2.5.4 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Oncology Small Molecule Drugs Product and Solutions
2.6.4 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Oncology Small Molecule Drugs Product and Solutions
2.7.4 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Oncology Small Molecule Drugs Product and Solutions
2.8.4 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Oncology Small Molecule Drugs Product and Solutions
2.9.4 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Oncology Small Molecule Drugs Product and Solutions
2.10.4 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Oncology Small Molecule Drugs Product and Solutions
2.11.4 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Eli Lilly Recent Developments and Future Plans
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business
2.12.3 Bayer Oncology Small Molecule Drugs Product and Solutions
2.12.4 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bayer Recent Developments and Future Plans
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Oncology Small Molecule Drugs Product and Solutions
2.13.4 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 AstraZeneca Recent Developments and Future Plans
2.14 Astellas
2.14.1 Astellas Details
2.14.2 Astellas Major Business
2.14.3 Astellas Oncology Small Molecule Drugs Product and Solutions
2.14.4 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Astellas Recent Developments and Future Plans
2.15 Merck
2.15.1 Merck Details
2.15.2 Merck Major Business
2.15.3 Merck Oncology Small Molecule Drugs Product and Solutions
2.15.4 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Merck Recent Developments and Future Plans
2.16 Biogen Idec
2.16.1 Biogen Idec Details
2.16.2 Biogen Idec Major Business
2.16.3 Biogen Idec Oncology Small Molecule Drugs Product and Solutions
2.16.4 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Biogen Idec Recent Developments and Future Plans
2.17 Eisai
2.17.1 Eisai Details
2.17.2 Eisai Major Business
2.17.3 Eisai Oncology Small Molecule Drugs Product and Solutions
2.17.4 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Eisai Recent Developments and Future Plans
2.18 Teva
2.18.1 Teva Details
2.18.2 Teva Major Business
2.18.3 Teva Oncology Small Molecule Drugs Product and Solutions
2.18.4 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Teva Recent Developments and Future Plans
2.19 Otsuka
2.19.1 Otsuka Details
2.19.2 Otsuka Major Business
2.19.3 Otsuka Oncology Small Molecule Drugs Product and Solutions
2.19.4 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Otsuka Recent Developments and Future Plans
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Oncology Small Molecule Drugs Product and Solutions
2.20.4 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Ipsen Recent Developments and Future Plans
2.21 Gilead Sciences
2.21.1 Gilead Sciences Details
2.21.2 Gilead Sciences Major Business
2.21.3 Gilead Sciences Oncology Small Molecule Drugs Product and Solutions
2.21.4 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Gilead Sciences Recent Developments and Future Plans
2.22 Exelixis
2.22.1 Exelixis Details
2.22.2 Exelixis Major Business
2.22.3 Exelixis Oncology Small Molecule Drugs Product and Solutions
2.22.4 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Exelixis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Small Molecule Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Small Molecule Drugs Players Market Share
3.2.2 Top 10 Oncology Small Molecule Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Oncology Small Molecule Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Oncology Small Molecule Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oncology Small Molecule Drugs Revenue Market Share by Application (2016-2021)
5.2 Oncology Small Molecule Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Small Molecule Drugs Revenue by Type (2016-2026)
6.2 North America Oncology Small Molecule Drugs Revenue by Application (2016-2026)
6.3 North America Oncology Small Molecule Drugs Market Size by Country
6.3.1 North America Oncology Small Molecule Drugs Revenue by Country (2016-2026)
6.3.2 United States Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Small Molecule Drugs Revenue by Type (2016-2026)
7.2 Europe Oncology Small Molecule Drugs Revenue by Application (2016-2026)
7.3 Europe Oncology Small Molecule Drugs Market Size by Country
7.3.1 Europe Oncology Small Molecule Drugs Revenue by Country (2016-2026)
7.3.2 Germany Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
7.3.3 France Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Small Molecule Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Oncology Small Molecule Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region
8.3.1 Asia-Pacific Oncology Small Molecule Drugs Revenue by Region (2016-2026)
8.3.2 China Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8.3.5 India Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Small Molecule Drugs Revenue by Type (2016-2026)
9.2 South America Oncology Small Molecule Drugs Revenue by Application (2016-2026)
9.3 South America Oncology Small Molecule Drugs Market Size by Country
9.3.1 South America Oncology Small Molecule Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Small Molecule Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Oncology Small Molecule Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country
10.3.1 Middle East & Africa Oncology Small Molecule Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Oncology Small Molecule Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Oncology Small Molecule Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oncology Small Molecule Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oncology Small Molecule Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oncology Small Molecule Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oncology Small Molecule Drugs Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Oncology Small Molecule Drugs Product and Solutions
Table 9. Roche Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Oncology Small Molecule Drugs Product and Solutions
Table 13. Novartis Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Oncology Small Molecule Drugs Product and Solutions
Table 17. Pfizer Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Celgene Corporate Information, Head Office, and Major Competitors
Table 19. Celgene Major Business
Table 20. Celgene Oncology Small Molecule Drugs Product and Solutions
Table 21. Celgene Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 23. Bristol-Myers Squibb Major Business
Table 24. Bristol-Myers Squibb Oncology Small Molecule Drugs Product and Solutions
Table 25. Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Oncology Small Molecule Drugs Product and Solutions
Table 29. Amgen Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Oncology Small Molecule Drugs Product and Solutions
Table 33. Johnson & Johnson Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AbbVie Corporate Information, Head Office, and Major Competitors
Table 35. AbbVie Major Business
Table 36. AbbVie Oncology Small Molecule Drugs Product and Solutions
Table 37. AbbVie Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Oncology Small Molecule Drugs Product and Solutions
Table 41. Sanofi Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Takeda Corporate Information, Head Office, and Major Competitors
Table 43. Takeda Major Business
Table 44. Takeda Oncology Small Molecule Drugs Product and Solutions
Table 45. Takeda Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 47. Eli Lilly Major Business
Table 48. Eli Lilly Oncology Small Molecule Drugs Product and Solutions
Table 49. Eli Lilly Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bayer Corporate Information, Head Office, and Major Competitors
Table 51. Bayer Major Business
Table 52. Bayer Oncology Small Molecule Drugs Product and Solutions
Table 53. Bayer Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 55. AstraZeneca Major Business
Table 56. AstraZeneca Oncology Small Molecule Drugs Product and Solutions
Table 57. AstraZeneca Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Astellas Corporate Information, Head Office, and Major Competitors
Table 59. Astellas Major Business
Table 60. Astellas Oncology Small Molecule Drugs Product and Solutions
Table 61. Astellas Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Merck Corporate Information, Head Office, and Major Competitors
Table 63. Merck Major Business
Table 64. Merck Oncology Small Molecule Drugs Product and Solutions
Table 65. Merck Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 67. Biogen Idec Major Business
Table 68. Biogen Idec Oncology Small Molecule Drugs Product and Solutions
Table 69. Biogen Idec Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Eisai Corporate Information, Head Office, and Major Competitors
Table 71. Eisai Major Business
Table 72. Eisai Oncology Small Molecule Drugs Product and Solutions
Table 73. Eisai Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Teva Corporate Information, Head Office, and Major Competitors
Table 75. Teva Major Business
Table 76. Teva Oncology Small Molecule Drugs Product and Solutions
Table 77. Teva Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Otsuka Corporate Information, Head Office, and Major Competitors
Table 79. Otsuka Major Business
Table 80. Otsuka Oncology Small Molecule Drugs Product and Solutions
Table 81. Otsuka Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Ipsen Corporate Information, Head Office, and Major Competitors
Table 83. Ipsen Major Business
Table 84. Ipsen Oncology Small Molecule Drugs Product and Solutions
Table 85. Ipsen Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 87. Gilead Sciences Major Business
Table 88. Gilead Sciences Oncology Small Molecule Drugs Product and Solutions
Table 89. Gilead Sciences Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Exelixis Corporate Information, Head Office, and Major Competitors
Table 91. Exelixis Major Business
Table 92. Exelixis Oncology Small Molecule Drugs Product and Solutions
Table 93. Exelixis Oncology Small Molecule Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Global Oncology Small Molecule Drugs Revenue (USD Million) by Players (2019-2021)
Table 95. Global Oncology Small Molecule Drugs Revenue Share by Players (2019-2021)
Table 96. Breakdown of Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. Oncology Small Molecule Drugs Players Head Office, Products and Services Provided
Table 98. Oncology Small Molecule Drugs Mergers & Acquisitions in the Past Five Years
Table 99. Oncology Small Molecule Drugs New Entrants and Expansion Plans
Table 100. Global Oncology Small Molecule Drugs Revenue (USD Million) by Type (2016-2021)
Table 101. Global Oncology Small Molecule Drugs Revenue Share by Type (2016-2021)
Table 102. Global Oncology Small Molecule Drugs Revenue Forecast by Type (2021-2026)
Table 103. Global Oncology Small Molecule Drugs Revenue by Application (2016-2021)
Table 104. Global Oncology Small Molecule Drugs Revenue Forecast by Application (2021-2026)
Table 105. North America Oncology Small Molecule Drugs Revenue by Type (2016-2021) & (USD Million)
Table 106. North America Oncology Small Molecule Drugs Revenue by Type (2021-2026) & (USD Million)
Table 107. North America Oncology Small Molecule Drugs Revenue by Application (2016-2021) & (USD Million)
Table 108. North America Oncology Small Molecule Drugs Revenue by Application (2021-2026) & (USD Million)
Table 109. North America Oncology Small Molecule Drugs Revenue by Country (2016-2021) & (USD Million)
Table 110. North America Oncology Small Molecule Drugs Revenue by Country (2021-2026) & (USD Million)
Table 111. Europe Oncology Small Molecule Drugs Revenue by Type (2016-2021) & (USD Million)
Table 112. Europe Oncology Small Molecule Drugs Revenue by Type (2021-2026) & (USD Million)
Table 113. Europe Oncology Small Molecule Drugs Revenue by Application (2016-2021) & (USD Million)
Table 114. Europe Oncology Small Molecule Drugs Revenue by Application (2021-2026) & (USD Million)
Table 115. Europe Oncology Small Molecule Drugs Revenue by Country (2016-2021) & (USD Million)
Table 116. Europe Oncology Small Molecule Drugs Revenue by Country (2021-2026) & (USD Million)
Table 117. Asia-Pacific Oncology Small Molecule Drugs Revenue by Type (2016-2021) & (USD Million)
Table 118. Asia-Pacific Oncology Small Molecule Drugs Revenue by Type (2021-2026) & (USD Million)
Table 119. Asia-Pacific Oncology Small Molecule Drugs Revenue by Application (2016-2021) & (USD Million)
Table 120. Asia-Pacific Oncology Small Molecule Drugs Revenue by Application (2021-2026) & (USD Million)
Table 121. Asia-Pacific Oncology Small Molecule Drugs Revenue by Region (2016-2021) & (USD Million)
Table 122. Asia-Pacific Oncology Small Molecule Drugs Revenue by Region (2021-2026) & (USD Million)
Table 123. South America Oncology Small Molecule Drugs Revenue by Type (2016-2021) & (USD Million)
Table 124. South America Oncology Small Molecule Drugs Revenue by Type (2021-2026) & (USD Million)
Table 125. South America Oncology Small Molecule Drugs Revenue by Application (2016-2021) & (USD Million)
Table 126. South America Oncology Small Molecule Drugs Revenue by Application (2021-2026) & (USD Million)
Table 127. South America Oncology Small Molecule Drugs Revenue by Country (2016-2021) & (USD Million)
Table 128. South America Oncology Small Molecule Drugs Revenue by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa Oncology Small Molecule Drugs Revenue by Type (2016-2021) & (USD Million)
Table 130. Middle East & Africa Oncology Small Molecule Drugs Revenue by Type (2021-2026) & (USD Million)
Table 131. Middle East & Africa Oncology Small Molecule Drugs Revenue by Application (2016-2021) & (USD Million)
Table 132. Middle East & Africa Oncology Small Molecule Drugs Revenue by Application (2021-2026) & (USD Million)
Table 133. Middle East & Africa Oncology Small Molecule Drugs Revenue by Country (2016-2021) & (USD Million)
Table 134. Middle East & Africa Oncology Small Molecule Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oncology Small Molecule Drugs Picture
Figure 2. Global Oncology Small Molecule Drugs Revenue Market Share by Type in 2020
Figure 3. Chemotherapy Drugs
Figure 4. Immunomodulating Drugs
Figure 5. Targeted Therapy Drugs
Figure 6. Hormonal Therapy
Figure 7. Other
Figure 8. Oncology Small Molecule Drugs Revenue Market Share by Application in 2020
Figure 9. Blood Cancer Picture
Figure 10. Breast Cancer Picture
Figure 11. Gastrointestinal Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Lung Cancer Picture
Figure 14. Other Picture
Figure 15. Global Oncology Small Molecule Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Oncology Small Molecule Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Oncology Small Molecule Drugs Revenue Market Share by Region (2016-2026)
Figure 18. Global Oncology Small Molecule Drugs Revenue Market Share by Region in 2020
Figure 19. North America Oncology Small Molecule Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Oncology Small Molecule Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Oncology Small Molecule Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Oncology Small Molecule Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Oncology Small Molecule Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Oncology Small Molecule Drugs Market Drivers
Figure 25. Oncology Small Molecule Drugs Market Restraints
Figure 26. Oncology Small Molecule Drugs Market Trends
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Celgene Recent Developments and Future Plans
Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 32. Amgen Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. AbbVie Recent Developments and Future Plans
Figure 35. Sanofi Recent Developments and Future Plans
Figure 36. Takeda Recent Developments and Future Plans
Figure 37. Eli Lilly Recent Developments and Future Plans
Figure 38. Bayer Recent Developments and Future Plans
Figure 39. AstraZeneca Recent Developments and Future Plans
Figure 40. Astellas Recent Developments and Future Plans
Figure 41. Merck Recent Developments and Future Plans
Figure 42. Biogen Idec Recent Developments and Future Plans
Figure 43. Eisai Recent Developments and Future Plans
Figure 44. Teva Recent Developments and Future Plans
Figure 45. Otsuka Recent Developments and Future Plans
Figure 46. Ipsen Recent Developments and Future Plans
Figure 47. Gilead Sciences Recent Developments and Future Plans
Figure 48. Exelixis Recent Developments and Future Plans
Figure 49. Global Oncology Small Molecule Drugs Revenue Share by Players in 2020
Figure 50. Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 51. Global Top 3 Players Oncology Small Molecule Drugs Revenue Market Share in 2020
Figure 52. Global Top 10 Players Oncology Small Molecule Drugs Revenue Market Share in 2020
Figure 53. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 54. Global Oncology Small Molecule Drugs Revenue Share by Type in 2020
Figure 55. Global Oncology Small Molecule Drugs Market Share Forecast by Type (2021-2026)
Figure 56. Global Oncology Small Molecule Drugs Revenue Share by Application in 2020
Figure 57. Global Oncology Small Molecule Drugs Market Share Forecast by Application (2021-2026)
Figure 58. North America Oncology Small Molecule Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Oncology Small Molecule Drugs Sales Market Share by Application (2016-2026)
Figure 60. North America Oncology Small Molecule Drugs Revenue Market Share by Country (2016-2026)
Figure 61. United States Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Canada Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Mexico Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Europe Oncology Small Molecule Drugs Sales Market Share by Type (2016-2026)
Figure 65. Europe Oncology Small Molecule Drugs Sales Market Share by Application (2016-2026)
Figure 66. Europe Oncology Small Molecule Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Germany Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. France Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. United Kingdom Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Russia Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Italy Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Asia-Pacific Oncology Small Molecule Drugs Sales Market Share by Type (2016-2026)
Figure 73. Asia-Pacific Oncology Small Molecule Drugs Sales Market Share by Application (2016-2026)
Figure 74. Asia-Pacific Oncology Small Molecule Drugs Revenue Market Share by Region (2016-2026)
Figure 75. China Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Japan Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Korea Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. India Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Southeast Asia Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Australia Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South America Oncology Small Molecule Drugs Sales Market Share by Type (2016-2026)
Figure 82. South America Oncology Small Molecule Drugs Sales Market Share by Application (2016-2026)
Figure 83. South America Oncology Small Molecule Drugs Revenue Market Share by Country (2016-2026)
Figure 84. Brazil Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Argentina Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Middle East and Africa Oncology Small Molecule Drugs Sales Market Share by Type (2016-2026)
Figure 87. Middle East and Africa Oncology Small Molecule Drugs Sales Market Share by Application (2016-2026)
Figure 88. Middle East and Africa Oncology Small Molecule Drugs Revenue Market Share by Country (2016-2026)
Figure 89. Turkey Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Saudi Arabia Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. UAE Oncology Small Molecule Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 92. Methodology
Figure 93. Research Process and Data Source
世界の腫瘍学小分子薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…- 世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…
- 世界の腫瘍ジェネリック注射薬市場 2021：企業別、地域別、種類・用途別 The Oncology Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 非小細胞肺がん治療薬の世界市場 2019年版：種類別（生物製剤、小分子標的療法、化学療法、その他）、用途別（肺腺がん、扁平上皮肺がん、大細胞肺がん） Scope of the Report: The global Non-small Cell Lung Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…
- 世界の腫瘍薬市場予測（～2024年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: Oncology Drugs is widely used For Blood Cancer, Bre…